Outlook Therapeutics (OTLK) P/E (2016 - 2026)
Outlook Therapeutics (OTLK) P/E from Jun 14, 2016 to Jul 21, 2026. The TTM Outlook Therapeutics (OTLK) P/E is -1.28. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Outlook Therapeutics (OTLK)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.28 | +100.52% |
| 2025 | -0.64 | -20.37% |
| 2024 | -0.80 | -53.54% |
| 2023 | -1.72 | -53.29% |
| 2022 | -3.69 | -22.43% |
| 2021 | -4.76 | +2.16% |
| 2020 | -4.66 | +730.02% |
| 2019 | -0.56 | -90.27% |
| 2018 | -5.77 | -10.36% |
| 2017 | -6.44 | -1.42% |
| 2016 | -6.53 | N/A |
Comparison Outlook Therapeutics (OTLK) P/E with competitors
Outlook Therapeutics (OTLK) P/E is -1.28.